Click for best price
Cancer Oncology Testing Market Size, Share 2024
The global Cancer Oncology Testing market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Fluorescence In Situ Hybridization Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Cancer Oncology Testing include Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, Pacific Biosciences of California, Qiagen, Agilent Technologies and Natera, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Oncology Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Oncology Testing. This report contains market size and forecasts of Cancer Oncology Testing in global, including the following market information:
Global Cancer Oncology Testing Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Cancer Oncology Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Oncology Testing Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Cancer Oncology Testing Market Segment Percentages, by Type, 2023 (%)
Fluorescence In Situ Hybridization
Polymerase Chain Reaction
Microarray Technology
Serum Proteomics
Nucleic Acid Sequencing
Global Cancer Oncology Testing Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Cancer Oncology Testing Market Segment Percentages, by Application, 2023 (%)
Hospitals
Speciality Clinics
Research Institutes
Diagnostics Laboratories
Biopharmaceutical Companies
Global Cancer Oncology Testing Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Cancer Oncology Testing Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Oncology Testing revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Cancer Oncology Testing revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Oncology Testing, market overview.
Chapter 2: Global Cancer Oncology Testing market size in revenue.
Chapter 3: Detailed analysis of Cancer Oncology Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Oncology Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cancer Oncology Testing Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Oncology Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Oncology Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Oncology Testing Overall Market Size
2.1 Global Cancer Oncology Testing Market Size: 2023 VS 2030
2.2 Global Cancer Oncology Testing Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Oncology Testing Players in Global Market
3.2 Top Global Cancer Oncology Testing Companies Ranked by Revenue
3.3 Global Cancer Oncology Testing Revenue by Companies
3.4 Top 3 and Top 5 Cancer Oncology Testing Companies in Global Market, by Revenue in 2023
3.5 Global Companies Cancer Oncology Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Oncology Testing Players in Global Market
3.6.1 List of Global Tier 1 Cancer Oncology Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Oncology Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Oncology Testing Market Size Markets, 2023 & 2030
4.1.2 Fluorescence In Situ Hybridization
4.1.3 Polymerase Chain Reaction
4.1.4 Microarray Technology
4.1.5 Serum Proteomics
4.1.6 Nucleic Acid Sequencing
4.2 By Type - Global Cancer Oncology Testing Revenue & Forecasts
4.2.1 By Type - Global Cancer Oncology Testing Revenue, 2019-2024
4.2.2 By Type - Global Cancer Oncology Testing Revenue, 2025-2030
4.2.3 By Type - Global Cancer Oncology Testing Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Oncology Testing Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Speciality Clinics
5.1.4 Research Institutes
5.1.5 Diagnostics Laboratories
5.1.6 Biopharmaceutical Companies
5.2 By Application - Global Cancer Oncology Testing Revenue & Forecasts
5.2.1 By Application - Global Cancer Oncology Testing Revenue, 2019-2024
5.2.2 By Application - Global Cancer Oncology Testing Revenue, 2025-2030
5.2.3 By Application - Global Cancer Oncology Testing Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Cancer Oncology Testing Market Size, 2023 & 2030
6.2 By Region - Global Cancer Oncology Testing Revenue & Forecasts
6.2.1 By Region - Global Cancer Oncology Testing Revenue, 2019-2024
6.2.2 By Region - Global Cancer Oncology Testing Revenue, 2025-2030
6.2.3 By Region - Global Cancer Oncology Testing Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Cancer Oncology Testing Revenue, 2019-2030
6.3.2 US Cancer Oncology Testing Market Size, 2019-2030
6.3.3 Canada Cancer Oncology Testing Market Size, 2019-2030
6.3.4 Mexico Cancer Oncology Testing Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Cancer Oncology Testing Revenue, 2019-2030
6.4.2 Germany Cancer Oncology Testing Market Size, 2019-2030
6.4.3 France Cancer Oncology Testing Market Size, 2019-2030
6.4.4 U.K. Cancer Oncology Testing Market Size, 2019-2030
6.4.5 Italy Cancer Oncology Testing Market Size, 2019-2030
6.4.6 Russia Cancer Oncology Testing Market Size, 2019-2030
6.4.7 Nordic Countries Cancer Oncology Testing Market Size, 2019-2030
6.4.8 Benelux Cancer Oncology Testing Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Cancer Oncology Testing Revenue, 2019-2030
6.5.2 China Cancer Oncology Testing Market Size, 2019-2030
6.5.3 Japan Cancer Oncology Testing Market Size, 2019-2030
6.5.4 South Korea Cancer Oncology Testing Market Size, 2019-2030
6.5.5 Southeast Asia Cancer Oncology Testing Market Size, 2019-2030
6.5.6 India Cancer Oncology Testing Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Cancer Oncology Testing Revenue, 2019-2030
6.6.2 Brazil Cancer Oncology Testing Market Size, 2019-2030
6.6.3 Argentina Cancer Oncology Testing Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Oncology Testing Revenue, 2019-2030
6.7.2 Turkey Cancer Oncology Testing Market Size, 2019-2030
6.7.3 Israel Cancer Oncology Testing Market Size, 2019-2030
6.7.4 Saudi Arabia Cancer Oncology Testing Market Size, 2019-2030
6.7.5 UAE Cancer Oncology Testing Market Size, 2019-2030
7 Cancer Oncology Testing Companies Profiles
7.1 Devyser
7.1.1 Devyser Company Summary
7.1.2 Devyser Business Overview
7.1.3 Devyser Cancer Oncology Testing Major Product Offerings
7.1.4 Devyser Cancer Oncology Testing Revenue in Global Market (2019-2024)
7.1.5 Devyser Key News & Latest Developments
7.2 Agendia
7.2.1 Agendia Company Summary
7.2.2 Agendia Business Overview
7.2.3 Agendia Cancer Oncology Testing Major Product Offerings
7.2.4 Agendia Cancer Oncology Testing Revenue in Global Market (2019-2024)
7.2.5 Agendia Key News & Latest Developments
7.3 Illumina
7.3.1 Illumina Company Summary
7.3.2 Illumina Business Overview
7.3.3 Illumina Cancer Oncology Testing Major Product Offerings
7.3.4 Illumina Cancer Oncology Testing Revenue in Global Market (2019-2024)
7.3.5 Illumina Key News & Latest Developments
7.4 Personal Genome Diagnostics
7.4.1 Personal Genome Diagnostics Company Summary
7.4.2 Personal Genome Diagnostics Business Overview
7.4.3 Personal Genome Diagnostics Cancer Oncology Testing Major Product Offerings
7.4.4 Personal Genome Diagnostics Cancer Oncology Testing Revenue in Global Market (2019-2024)
7.4.5 Personal Genome Diagnostics Key News & Latest Developments
7.5 Veracyte
7.5.1 Veracyte Company Summary
7.5.2 Veracyte Business Overview
7.5.3 Veracyte Cancer Oncology Testing Major Product Offerings
7.5.4 Veracyte Cancer Oncology Testing Revenue in Global Market (2019-2024)
7.5.5 Veracyte Key News & Latest Developments
7.6 Pacific Biosciences of California
7.6.1 Pacific Biosciences of California Company Summary
7.6.2 Pacific Biosciences of California Business Overview
7.6.3 Pacific Biosciences of California Cancer Oncology Testing Major Product Offerings
7.6.4 Pacific Biosciences of California Cancer Oncology Testing Revenue in Global Market (2019-2024)
7.6.5 Pacific Biosciences of California Key News & Latest Developments
7.7 Qiagen
7.7.1 Qiagen Company Summary
7.7.2 Qiagen Business Overview
7.7.3 Qiagen Cancer Oncology Testing Major Product Offerings
7.7.4 Qiagen Cancer Oncology Testing Revenue in Global Market (2019-2024)
7.7.5 Qiagen Key News & Latest Developments
7.8 Agilent Technologies
7.8.1 Agilent Technologies Company Summary
7.8.2 Agilent Technologies Business Overview
7.8.3 Agilent Technologies Cancer Oncology Testing Major Product Offerings
7.8.4 Agilent Technologies Cancer Oncology Testing Revenue in Global Market (2019-2024)
7.8.5 Agilent Technologies Key News & Latest Developments
7.9 Natera
7.9.1 Natera Company Summary
7.9.2 Natera Business Overview
7.9.3 Natera Cancer Oncology Testing Major Product Offerings
7.9.4 Natera Cancer Oncology Testing Revenue in Global Market (2019-2024)
7.9.5 Natera Key News & Latest Developments
7.10 Bio Rad Laboratories
7.10.1 Bio Rad Laboratories Company Summary
7.10.2 Bio Rad Laboratories Business Overview
7.10.3 Bio Rad Laboratories Cancer Oncology Testing Major Product Offerings
7.10.4 Bio Rad Laboratories Cancer Oncology Testing Revenue in Global Market (2019-2024)
7.10.5 Bio Rad Laboratories Key News & Latest Developments
7.11 Myriad Genetics
7.11.1 Myriad Genetics Company Summary
7.11.2 Myriad Genetics Business Overview
7.11.3 Myriad Genetics Cancer Oncology Testing Major Product Offerings
7.11.4 Myriad Genetics Cancer Oncology Testing Revenue in Global Market (2019-2024)
7.11.5 Myriad Genetics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Oncology Testing Market Opportunities & Trends in Global Market
Table 2. Cancer Oncology Testing Market Drivers in Global Market
Table 3. Cancer Oncology Testing Market Restraints in Global Market
Table 4. Key Players of Cancer Oncology Testing in Global Market
Table 5. Top Cancer Oncology Testing Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Cancer Oncology Testing Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Cancer Oncology Testing Revenue Share by Companies, 2019-2024
Table 8. Global Companies Cancer Oncology Testing Product Type
Table 9. List of Global Tier 1 Cancer Oncology Testing Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Oncology Testing Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Cancer Oncology Testing Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Cancer Oncology Testing Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Cancer Oncology Testing Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Cancer Oncology Testing Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Cancer Oncology Testing Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Cancer Oncology Testing Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Cancer Oncology Testing Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Cancer Oncology Testing Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Cancer Oncology Testing Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Cancer Oncology Testing Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Cancer Oncology Testing Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Cancer Oncology Testing Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Cancer Oncology Testing Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Cancer Oncology Testing Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Cancer Oncology Testing Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Cancer Oncology Testing Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Cancer Oncology Testing Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Cancer Oncology Testing Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Cancer Oncology Testing Revenue, (US$, Mn), 2025-2030
Table 30. Devyser Company Summary
Table 31. Devyser Cancer Oncology Testing Product Offerings
Table 32. Devyser Cancer Oncology Testing Revenue (US$, Mn) & (2019-2024)
Table 33. Devyser Key News & Latest Developments
Table 34. Agendia Company Summary
Table 35. Agendia Cancer Oncology Testing Product Offerings
Table 36. Agendia Cancer Oncology Testing Revenue (US$, Mn) & (2019-2024)
Table 37. Agendia Key News & Latest Developments
Table 38. Illumina Company Summary
Table 39. Illumina Cancer Oncology Testing Product Offerings
Table 40. Illumina Cancer Oncology Testing Revenue (US$, Mn) & (2019-2024)
Table 41. Illumina Key News & Latest Developments
Table 42. Personal Genome Diagnostics Company Summary
Table 43. Personal Genome Diagnostics Cancer Oncology Testing Product Offerings
Table 44. Personal Genome Diagnostics Cancer Oncology Testing Revenue (US$, Mn) & (2019-2024)
Table 45. Personal Genome Diagnostics Key News & Latest Developments
Table 46. Veracyte Company Summary
Table 47. Veracyte Cancer Oncology Testing Product Offerings
Table 48. Veracyte Cancer Oncology Testing Revenue (US$, Mn) & (2019-2024)
Table 49. Veracyte Key News & Latest Developments
Table 50. Pacific Biosciences of California Company Summary
Table 51. Pacific Biosciences of California Cancer Oncology Testing Product Offerings
Table 52. Pacific Biosciences of California Cancer Oncology Testing Revenue (US$, Mn) & (2019-2024)
Table 53. Pacific Biosciences of California Key News & Latest Developments
Table 54. Qiagen Company Summary
Table 55. Qiagen Cancer Oncology Testing Product Offerings
Table 56. Qiagen Cancer Oncology Testing Revenue (US$, Mn) & (2019-2024)
Table 57. Qiagen Key News & Latest Developments
Table 58. Agilent Technologies Company Summary
Table 59. Agilent Technologies Cancer Oncology Testing Product Offerings
Table 60. Agilent Technologies Cancer Oncology Testing Revenue (US$, Mn) & (2019-2024)
Table 61. Agilent Technologies Key News & Latest Developments
Table 62. Natera Company Summary
Table 63. Natera Cancer Oncology Testing Product Offerings
Table 64. Natera Cancer Oncology Testing Revenue (US$, Mn) & (2019-2024)
Table 65. Natera Key News & Latest Developments
Table 66. Bio Rad Laboratories Company Summary
Table 67. Bio Rad Laboratories Cancer Oncology Testing Product Offerings
Table 68. Bio Rad Laboratories Cancer Oncology Testing Revenue (US$, Mn) & (2019-2024)
Table 69. Bio Rad Laboratories Key News & Latest Developments
Table 70. Myriad Genetics Company Summary
Table 71. Myriad Genetics Cancer Oncology Testing Product Offerings
Table 72. Myriad Genetics Cancer Oncology Testing Revenue (US$, Mn) & (2019-2024)
Table 73. Myriad Genetics Key News & Latest Developments
List of Figures
Figure 1. Cancer Oncology Testing Segment by Type in 2023
Figure 2. Cancer Oncology Testing Segment by Application in 2023
Figure 3. Global Cancer Oncology Testing Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Cancer Oncology Testing Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Cancer Oncology Testing Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Oncology Testing Revenue in 2023
Figure 8. By Type - Global Cancer Oncology Testing Revenue Market Share, 2019-2030
Figure 9. By Application - Global Cancer Oncology Testing Revenue Market Share, 2019-2030
Figure 10. By Type - Global Cancer Oncology Testing Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Cancer Oncology Testing Revenue Market Share, 2019-2030
Figure 12. By Application - Global Cancer Oncology Testing Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Cancer Oncology Testing Revenue Market Share, 2019-2030
Figure 14. By Region - Global Cancer Oncology Testing Revenue Market Share, 2019-2030
Figure 15. By Country - North America Cancer Oncology Testing Revenue Market Share, 2019-2030
Figure 16. US Cancer Oncology Testing Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Cancer Oncology Testing Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Cancer Oncology Testing Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Cancer Oncology Testing Revenue Market Share, 2019-2030
Figure 20. Germany Cancer Oncology Testing Revenue, (US$, Mn), 2019-2030
Figure 21. France Cancer Oncology Testing Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Cancer Oncology Testing Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Cancer Oncology Testing Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Cancer Oncology Testing Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Cancer Oncology Testing Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Cancer Oncology Testing Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Cancer Oncology Testing Revenue Market Share, 2019-2030
Figure 28. China Cancer Oncology Testing Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Cancer Oncology Testing Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Cancer Oncology Testing Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Cancer Oncology Testing Revenue, (US$, Mn), 2019-2030
Figure 32. India Cancer Oncology Testing Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Cancer Oncology Testing Revenue Market Share, 2019-2030
Figure 34. Brazil Cancer Oncology Testing Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Cancer Oncology Testing Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Cancer Oncology Testing Revenue Market Share, 2019-2030
Figure 37. Turkey Cancer Oncology Testing Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Cancer Oncology Testing Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Cancer Oncology Testing Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Cancer Oncology Testing Revenue, (US$, Mn), 2019-2030
Figure 41. Devyser Cancer Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Agendia Cancer Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Illumina Cancer Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Personal Genome Diagnostics Cancer Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Veracyte Cancer Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Pacific Biosciences of California Cancer Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Qiagen Cancer Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Agilent Technologies Cancer Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Natera Cancer Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Bio Rad Laboratories Cancer Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Myriad Genetics Cancer Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
